As of January 22, 2025, 4D Molecular Therapeutics (FDMT) has a market cap of $0.21 billion USD. According to our data, 4D Molecular Therapeutics is ranked No.7047 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.21 B |
-17.24%
|
Dec 31, 2024 | $0.26 B |
-72.51%
|
Dec 29, 2023 | $0.94 B |
-8.78%
|
Dec 30, 2022 | $1.03 B |
1.23%
|
Dec 31, 2021 | $1.01 B |
-47.07%
|
Dec 31, 2020 | $1.92 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Adverum Biotechnologies
ADVM
|
$92.99 M |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
MeiraGTx
MGTX
|
$0.47 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Solid Biosciences
SLDB
|
$0.12 B |
-0.000 M
|
USA
|
Generation Bio
GBIO
|
$63.83 M |
-0.000 M
|
USA
|
Market Cap | = | FDMT Stock Price | * | FDMT Shares Outstanding |
= | $4.61 | * | 46.23 M | |
= | $0.21 B |